S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
CVE:RX

BioSyent (RX) Stock Price, News & Analysis

C$8.70
0.00 (0.00%)
(As of 03/28/2024 05:23 PM ET)
Today's Range
C$8.67
C$8.70
50-Day Range
C$8.40
C$8.78
52-Week Range
C$7.03
C$9.26
Volume
3,178 shs
Average Volume
4,962 shs
Market Capitalization
C$101.01 million
P/E Ratio
16.42
Dividend Yield
2.07%
Price Target
N/A
RX stock logo

About BioSyent Stock (CVE:RX)

BioSyent Inc., a specialty pharmaceutical company, sources, acquires or in-licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX 150, an oral hematinic; FeraMAX Powder, a water or mixing oral iron supplement; and FeraMAX Pd Therapeutic 150 for the prevention and treatment of iron deficiency anemia. It also offers Cathejell, a product indicated for surface anesthesia and lubrication during various procedures, including cystoscopy, catheterization, endourethral operation, endoscopy, proctoscopy, rectoscopy, and tracheal intubation, as well as used for the symptomatic treatment of pain in connection with cystitis and urethritis; RepaGyn, a vaginal suppository for the healing of the vaginal mucosa, as well as for the treatment of vaginal dryness caused by menopause, stress, and chemotherapy; and Proktis-M, a rectal suppository for the healing of the anus and rectum. In addition, it provides Combogesic for moderate acute pain and reduction of fever in adults; Protect-It, a non-chemical food-safe grain insecticide product used as a preventative treatment against insect infestations in stored grains; and Tibella, a hormone replacement therapy to treat vasomotor symptoms due to estrogen deficiency, as well as Feramax Pd Maintenance 45, a chewable, orange-flavored iron supplement. The company sells its products through wholesalers and retail pharmacy chains. The company was formerly known as Hedley Technologies Inc. and changed its name to BioSyent Inc. in June 2006 to reflect its forward focus on the pharmaceutical market. BioSyent Inc. was incorporated in 2006 and is headquartered in Mississauga, Canada.

RX Stock Price History

RX Stock News Headlines

[BUY ALERT] Our #1 A.I. Stock for March
It's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.
BioSyent Named to 2024 TSX Venture 50
RX:CA BioSyent Inc.
BioSyent Declares First Quarter 2024 Dividend
[BUY ALERT] Our #1 A.I. Stock for March
It's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.
Bloom Burton Believes Biosyent (RX) Won’t Stop Here
BioSyent Releases Q3 and YTD 2023 Financial Results
BioSyent Declares Fourth Quarter 2023 Dividend
Closing Bell: Biosyent Inc flat on Tuesday (RX)
Closing Bell: Biosyent Inc flat on Wednesday (RX)
BioSyent Declares Third Quarter 2023 Dividend
Closing Bell: Biosyent Inc down on Monday (RX)
BioSyent Announces Approval of New Product
See More Headlines
Receive RX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioSyent and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/13/2024
Today
3/29/2024
Next Earnings (Estimated)
5/24/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
C$6.46 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$31.59 million
Cash Flow
C$2.83 per share
Book Value
C$2.96 per share

Miscellaneous

Free Float
N/A
Market Cap
C$101.01 million
Optionable
Not Optionable
Beta
0.93
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. René C. Goehrum (Age 65)
    Chairman, CEO & President
    Comp: $534.76k
  • Mr. Robert J. March
    VP of Finance & CFO
  • Mr. Joost van der Mark
    Vice President of Corporate Development
  • Ms. Neelu Atwal
    Director of Human Resources
  • Mr. Alfred D'Souza
    Advisor

RX Stock Analysis - Frequently Asked Questions

How have RX shares performed in 2024?

BioSyent's stock was trading at C$9.22 at the start of the year. Since then, RX shares have decreased by 5.6% and is now trading at C$8.70.
View the best growth stocks for 2024 here
.

When is BioSyent's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, May 24th 2024.
View our RX earnings forecast
.

How were BioSyent's earnings last quarter?

BioSyent Inc. (CVE:RX) posted its quarterly earnings data on Wednesday, March, 13th. The company reported $0.12 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.17 by $0.05. The firm earned $8.27 million during the quarter, compared to the consensus estimate of $8.80 million. BioSyent had a net margin of 20.45% and a trailing twelve-month return on equity of 18.97%.

Is BioSyent a good dividend stock?

BioSyent (CVE:RX) pays an annual dividend of C$0.18 per share and currently has a dividend yield of 2.07%. The dividend payout ratio is 33.96%. This payout ratio is at a healthy, sustainable level, below 75%.

What other stocks do shareholders of BioSyent own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BioSyent investors own include Aurora Cannabis (ACB), Canadian National Railway (CNR), Bank of Nova Scotia (BNS), Cross Timbers Royalty Trust (CRT), Dollarama (DOL), Enbridge (ENB), Gilead Sciences (GILD), National Bank of Canada (NA) and Air Canada (AC).

How do I buy shares of BioSyent?

Shares of RX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:RX) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners